Structural Insights into PROTAC-Mediated Degradation of Bcl-xL.


Journal

ACS chemical biology
ISSN: 1554-8937
Titre abrégé: ACS Chem Biol
Pays: United States
ID NLM: 101282906

Informations de publication

Date de publication:
18 09 2020
Historique:
pubmed: 23 7 2020
medline: 9 6 2021
entrez: 23 7 2020
Statut: ppublish

Résumé

The Bcl-2 family of proteins, such as Bcl-xL and Bcl-2, play key roles in cancer cell survival. Structural studies of Bcl-xL formed the foundation for the development of the first Bcl-2 family inhibitors and FDA approved drugs. Recently,

Identifiants

pubmed: 32697072
doi: 10.1021/acschembio.0c00266
doi:

Substances chimiques

BCL2L1 protein, human 0
Benzothiazoles 0
Isoquinolines 0
Oligopeptides 0
bcl-X Protein 0
Von Hippel-Lindau Tumor Suppressor Protein EC 2.3.2.27
VHL protein, human EC 6.3.2.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2316-2323

Auteurs

Chun-Wa Chung (CW)

Protein, Cellular & Structural Sciences, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom.

Han Dai (H)

Protein Degradation Group, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States.

Esther Fernandez (E)

Protein Degradation Group, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom.

Christopher P Tinworth (CP)

Protein Degradation Group, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom.

Ian Churcher (I)

Protein Degradation Group, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom.

Jenni Cryan (J)

Protein Degradation Group, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom.

Jane Denyer (J)

Protein Degradation Group, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom.

John D Harling (JD)

Protein Degradation Group, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom.

Agnieszka Konopacka (A)

Protein Degradation Group, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom.

Markus A Queisser (MA)

Protein Degradation Group, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom.

Christopher J Tame (CJ)

Protein Degradation Group, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom.

Gillian Watt (G)

Protein Degradation Group, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom.

Fan Jiang (F)

Viva Biotech, Ltd., 334 Aidisheng Rd., Zhangjiang High-tech Park, Shanghai 201203, China.

Dongming Qian (D)

Viva Biotech, Ltd., 334 Aidisheng Rd., Zhangjiang High-tech Park, Shanghai 201203, China.

Andrew B Benowitz (AB)

Protein Degradation Group, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH